Clinical Trial Update: Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

A Phase 1 study of temsirolimus with valproic acid in children with relapsed neuroblastoma, osteosarcoma, soft tissue sarcoma, or brain tumor has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Neuroblastoma
• Osteosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Torisel (Temsirolimus)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Brain and Central Nervous System Tumors, Neuroblastoma | Phase 1 | Status: TERMINATED